Access DEA Events 
NORML
OCTOBER 21, 2019
Justices for the US Court of Appeals for the District of Columbia denied the petition following a filing by DEA in the Federal Register stating that the agency “intends to promulgate regulations” to review several dozen federal cultivation applications.
WeedAdvisor
JUNE 1, 2019
In a rather surprising turn of events, a federal appeals court gave marijuana advocates a small opening in their ongoing battle to reschedule marijuana, according to Marijuana Moment. The court, citing concerns over marijuana’s Schedule I status and its impact on medical users who need it most, essentially issued an ultimatum to the DEA.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Veriheal
JUNE 30, 2023
To start, participants reported that psilocybin had helped them process emotions tied to painful events in their past. Lastly, the guide lays out the complex DEA registration process researchers much navigate to gain access to plants like psilocybin. The Summit found that cannabis does not enhance athletic performance.
Dykema (Cannabis Law Blog)
SEPTEMBER 20, 2021
Marihuana Event Organizer. Temporary Marihuana Event. Event organizers would need to provide proof of coverage for all vendors at an event. Temporary marihuana event license; application; operations. Express municipal approval would be required for a temporary marihuana event. Excess Marihuana Grower.
Cannabis Law Report
AUGUST 12, 2022
Drug policy topics have become a consistent feature of the Austin-based event in recent years as more states have legalized cannabis and moved to reform laws around psychedelics like psilocybin locally and at the state level. Obtaining DEA License to Grow Psilocybin Mushrooms. Here are some psychedelics panel options: .
Cannabis Law Report
SEPTEMBER 23, 2021
The major concerns noted were adverse events following consumption (many from inadvertent intoxication), marketing to and use by minors, and the potential presence of harmful by-products and unsafe manufacturing practices. The FDA has received adverse event reports involving delta-8 THC-containing products. CDC Health Alert.
Cannabis Law Report
APRIL 8, 2022
Later that year, Doblin sued the DEA for the first time. submitted his first DEA application to manufacture marijuana for use in medical research. To celebrate this, we invite you to take a trip down memory lane and review highlights from every year of our history. Lyle Craker, Ph.D., MAPS Founder Rick Doblin, Ph.D.,
Expert insights. Personalized for you.
105 
Let's personalize your content